Curandus sp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2018-08-28
Share capital
50,000.00 PLN
Registered address
ul. Prosta 68, 00-838 Warszawa, Poland
Electronic delivery address
AE:PL-92703-40424-GRWDD-19
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 81 days late).
- 2024not filed
- 202309/07/2024
- 202204/07/2023
- 202104/10/2022
- 202008/10/2021
- 201915/10/2020
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Industry · Research and experimental development in natural sciences and engineering103 / 363
Top 28%
Voivodeship · Mazowieckie38,367 / 142,204
Top 27%
Country · Poland140,550 / 496,474
Top 28%
Results vs industry
Revenue
This companyUSD 736.53kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD 51.76kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 671.12kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 528.82kMedianUSD 281.58kAverageUSD 8.35m
Industry
Authorized Representatives
Simon David Holmes – Management Board Member
Simon Peter Hollywood – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-09-04.
68 1030 1508 0000 0008 2416 2837
80 1030 1508 0000 0008 2416 2330
66 1030 1508 0000 0008 2416 2000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oncotransfer sp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Smart Fluid S.A. | $681,963.98 | smartfluid.pl | ||
| Lymelab Pharma sp. z o.o. sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis Diagnostics S.A. | $282,613.94 | oasis-diagnostics.com | ||
| Nanosanguis S.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rnd sp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB Idea P.S.A. | $44,631.63 | vbidea.pl | ||
| Nanovelos S.A. | $24,842.03 | nanovelos.com | ||
| Bio2materials sp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostal sp. z o.o. | $8,607.48 | nanostal.com |
FAQ
The main business activity of Curandus focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on August 28, 2018.
The headquarters is located at: ul. Prosta 68, 00-838 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
The company reported a revenue of USD 736,526 in 2023, which is a decrease of 16.4% compared to 2022.
Yes, the company recorded a net profit of USD 51,755 in 2023, meaning the company decreased its profit by 65.2%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 338,315 in 2023, representing 50% of all operating expenses.
Last updated: 2026-08-13